Economic Costs of Diabetes in the U.S. in 2017 - PubMed (original) (raw)
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association. Diabetes Care. 2018 May.
Abstract
Objective: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2017.
Research design and methods: We use a prevalence-based approach that combines the demographics of the U.S. population in 2017 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S.
Results: The total estimated cost of diagnosed diabetes in 2017 is 327billion,including327 billion, including 327billion,including237 billion in direct medical costs and 90billioninreducedproductivity.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsfor1in4healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Peoplewithdiagnoseddiabetesincuraveragemedicalexpendituresof∼90 billion in reduced productivity. For the cost categories analyzed, care for people with diagnosed diabetes accounts for 1 in 4 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. People with diagnosed diabetes incur average medical expenditures of ∼90billioninreducedproductivity.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsfor1in4healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Peoplewithdiagnoseddiabetesincuraveragemedicalexpendituresof∼16,750 per year, of which ∼$9,600 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures ∼2.3 times higher than what expenditures would be in the absence of diabetes. Indirect costs include increased absenteeism ($3.3 billion) and reduced productivity while at work ($26.9 billion) for the employed population, reduced productivity for those not in the labor force ($2.3 billion), inability to work because of disease-related disability ($37.5 billion), and lost productivity due to 277,000 premature deaths attributed to diabetes ($19.9 billion).
Conclusions: After adjusting for inflation, economic costs of diabetes increased by 26% from 2012 to 2017 due to the increased prevalence of diabetes and the increased cost per person with diabetes. The growth in diabetes prevalence and medical costs is primarily among the population aged 65 years and older, contributing to a growing economic cost to the Medicare program. The estimates in this article highlight the substantial financial burden that diabetes imposes on society, in addition to intangible costs from pain and suffering, resources from care provided by nonpaid caregivers, and costs associated with undiagnosed diabetes.
© 2018 by the American Diabetes Association.
Figures
Figure 1
Percent of medical condition-specific expenditures associated with diabetes. Data sources: NIS (2014), CMS MDS (2013), NAMCS (2013–2015), NHAMCS (2012–2014), MEPS (2011–2015), NHHCS (2007), NHIS (2014–2016), OptumInsight dNHI (2015), and Medicare 5% SAFs (2014). See
Supplementary Appendix 2
for diagnosis codes for each category of medical condition.
Figure 2
Total direct costs of diabetes, 2007–2017.
Figure 3
Total indirect costs of diabetes, 2007–2017.
Figure 4
Total economic cost of diabetes, 2007–2017.
Figure 5
Average cost of diabetes, 2007–2017 (in 2017 dollars).
Similar articles
- Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review. - Economic costs of diabetes in the U.S. in 2012.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6. Diabetes Care. 2013. PMID: 23468086 Free PMC article. - Economic costs of diabetes in the US in 2002.
Hogan P, Dall T, Nikolov P; American Diabetes Association. Hogan P, et al. Diabetes Care. 2003 Mar;26(3):917-32. doi: 10.2337/diacare.26.3.917. Diabetes Care. 2003. PMID: 12610059 - Economic Costs of Diabetes in the U.S. in 2022.
Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Parker ED, et al. Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085. Diabetes Care. 2024. PMID: 37909353 Review. - Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
[No authors listed] [No authors listed] Diabetes Care. 1998 Feb;21(2):296-309. doi: 10.2337/diacare.21.2.296. Diabetes Care. 1998. PMID: 9539999
Cited by
- Amputation versus circular external fixation in the treatment of diabetic foot with osteomyelitis: a cost and quality-of-life analysis.
López Capdevilla L, Santamaría Fumas A, Sales Pérez JM, Domínguez Sevilla A, Del Corral Cuervo J, Varela-Quintana C, Rabanal Rubio M, Roza Miguel P. López Capdevilla L, et al. Ther Adv Endocrinol Metab. 2024 Oct 7;15:20420188241271795. doi: 10.1177/20420188241271795. eCollection 2024. Ther Adv Endocrinol Metab. 2024. PMID: 39483172 Free PMC article. - Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial.
Singh LG, Satyarengga M, Marcano I, Scott WH, Pinault LF, Feng Z, Sorkin JD, Umpierrez GE, Spanakis EK. Singh LG, et al. Diabetes Care. 2020 Nov;43(11):2736-2743. doi: 10.2337/dc20-0840. Epub 2020 Aug 5. Diabetes Care. 2020. PMID: 32759361 Free PMC article. - Recent Trends in Diabetes-Associated Hospitalizations in the United States.
Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, McCormack-Granja E. Rubens M, et al. J Clin Med. 2022 Nov 9;11(22):6636. doi: 10.3390/jcm11226636. J Clin Med. 2022. PMID: 36431114 Free PMC article. - Association between Sleep Duration and Left Ventricular Hypertrophy for Patients with Type 2 Diabetes Mellitus.
Mu L, Li C, Zhao W, Li A, Zhao D, Zhang B. Mu L, et al. Int J Endocrinol. 2023 Nov 28;2023:5532778. doi: 10.1155/2023/5532778. eCollection 2023. Int J Endocrinol. 2023. PMID: 38131034 Free PMC article. - ROCK1 regulates insulin secretion from β-cells.
Sung BJ, Lim SB, Yang WM, Kim JH, Kulkarni RN, Kim YB, Lee MK. Sung BJ, et al. Mol Metab. 2022 Dec;66:101625. doi: 10.1016/j.molmet.2022.101625. Epub 2022 Oct 29. Mol Metab. 2022. PMID: 36374631 Free PMC article.
References
- Centers for Disease Control and Prevention. National Diabetes Statistics Report [Internet], 2017. Available from https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed 30 November 2017.
- American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596–615 - PubMed
- U.S. Bureau of Labor Statistics. Consumer Price Index (CPI) databases [Internet]. Available from https://www.bls.gov/cpi/data.htm. Accessed 30 November 2017.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical